Literature DB >> 32052

Blockade by WB 4101 of alpha-adrenoceptors in the rat vas deferens and guinea-pig taenia caeci.

M Butler, D H Jenkinson.   

Abstract

The effectiveness of WB 4101, a recently described alpha-adrenoceptor antagonist, in blocking an excitatory and two inhibitory responses to alpha-receptor activation was studied. One of the inhibitory responses was the reduction by the selective alpha-agonist amidephrine of carbachol contractures of isolated guinea-pig taenia caeci. WB 4101 antagonised this inhibition with a Schild plot slope of 0.99 and a pA2 of 8.9. The same pA2 value was obtained for blockade of the contractile effect of amidephrine and noradrenaline on the rat vas deferens. WB 4101 was, however, several hundred times less active in antagonising the inhibitory effect of clonidine on the twitch response of the vas deferens to field stimulation. Incidental observations were that the twitch was increased by low concentrations of amidephrine, and by relatively high concentrations of WB 4101. Because of its potency and postsynaptic selectivity, WB 4101 should be useful for adrenoceptor classification.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 32052     DOI: 10.1016/0014-2999(78)90283-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

1.  Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit.

Authors:  R Weitzell; T Tanaka; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

2.  Effects of apamin on alpha-adrenoceptor-mediated changes in plasma potassium in guinea-pigs.

Authors:  R A Coats
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

3.  Pharmacological activity of ACC-7513, a selective alpha-adrenoceptor and 5-hydroxytryptamine receptor blocking agent.

Authors:  W G Anderson; S T Kam
Journal:  Br J Pharmacol       Date:  1985-04       Impact factor: 8.739

4.  The distribution of adrenoceptors and other drug receptors between the two ends of the rat vas deferens as revealed by selective agonists and antagonists.

Authors:  A MacDonald; J C McGrath
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

5.  Evidence in favour of a selective alpha 1-adrenoceptor blocking action of WB 4101 in vivo.

Authors:  G M Drew
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-06       Impact factor: 3.000

6.  Pre- and postsynaptic alpha-adrenoceptor blocking activity of raubasine in the rat vas deferens.

Authors:  P Demichel; P Gomond; J Roquebert
Journal:  Br J Pharmacol       Date:  1981-12       Impact factor: 8.739

7.  3H-WB 4101 binding in the rat vas deferens. Effects of chronic treatments with desipramine and prazosin.

Authors:  H W Wetzel; M S Briley; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

8.  Alpha 2-adrenoceptors modulating insulin release from isolated pancreatic islets.

Authors:  T Nakaki; T Nakadate; R Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

9.  An investigation of presynaptic alpha-adrenoceptor subtypes in the pithed rat heart and in the rat isolated vas deferens.

Authors:  J R Docherty
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

10.  The actions of cirazoline on the rat vas deferens.

Authors:  J R Docherty; J C McGrath
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.